Galbraith Kenneth bought ZYME
January 5, 2026 · Form 4 insider transaction
Galbraith Kenneth bought 66,666 shares of Zymeworks Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
66,666
Price
$0.00
Total value
N/A
InsiderGalbraith Kenneth
RoleOfficer, Director
CompanyZymeworks Inc. (ZYME)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 5, 2026
Filing dateJanuary 5, 2026
Shares owned after224,952
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of common stock issued upon vesting of one third of the RSUs granted on January 5, 2024.